IVF · Embryo transfer timing
Day-3 versus day-5 embryo transfer — when each is the right choice
Embryos can be transferred on day 3 (cleavage stage) or day 5 (blastocyst stage) after oocyte retrieval. Each timing has clinical situations where it is the right choice. This page explains the difference, the evidence on outcomes, and how the decision is made in each cycle.
Cleavage stage versus blastocyst
- Day-3 (cleavage) — embryo has 6–10 cells; transferred earlier in development
- Day-5 (blastocyst) — embryo has 60–150 cells, has differentiated into inner cell mass and trophectoderm; transferred at a later, more advanced stage
Roughly 40–60 per cent of well-fertilised oocytes that progress through day 3 will reach blastocyst by day 5. The remainder arrest along the way.
Why day-5 has become standard for many cycles
- Embryos that reach blastocyst have demonstrated developmental competence
- Selection at day 5 is more discriminating than at day 3
- Cumulative live birth rates favour blastocyst transfer in most randomised data
- Day-5 transfer enables single embryo transfer with high success, reducing multiple pregnancy risk
- Blastocysts are easier targets for PGT trophectoderm biopsy
When day-3 transfer is the right choice
- Small number of embryos at day 3 (e.g. ≤3) where waiting risks none reaching blastocyst
- Prior poor blastocyst conversion in previous cycles
- Advanced maternal age with low embryo numbers
- Patient preference after structured counselling
- Practical or geographical reasons that make day-5 retrieval timing difficult (rare)
When day-5 is preferred
- Good number of embryos at day 3 (typically ≥4)
- Good fertilisation rate and good early-cleavage quality
- Cycle is being planned with PGT
- Single embryo transfer is the goal
- Patient has had previous day-3 transfer failures with good morphology embryos
Embryo grading
At blastocyst stage, the Gardner grading system describes expansion, inner cell mass (ICM) quality, and trophectoderm (TE) quality — e.g. 4AA, 3BB, 5AA. Grading is one input into selection; it is correlated with implantation but is not a guarantee. AI-assisted morphometric grading is an emerging supplement, used with appropriate caution.
The decision in practice
The decision between day-3 and day-5 is made on day 3 itself, with the embryologist and clinician reviewing the embryos together. The patient is updated and a recommendation is shared. The default in most cycles at this centre is day-5 blastocyst transfer; day-3 is selected when the embryo numbers or developmental trajectory make it the safer choice.
Outcomes
Per-cycle live birth rates are similar to slightly favouring day-5 transfer in good-prognosis patients. Cumulative live birth rates across fresh + frozen transfers from one stimulation are broadly equivalent in many studies. The main practical advantage of day-5 is enabling single embryo transfer and reducing multiple pregnancy.
Guidelines we follow on this topic
- ESHRE Guideline on Embryo Transfer
- Cochrane review on blastocyst vs cleavage stage transfer
- NICE fertility guidance
Related reading
Dr. Priyadatt Patel
Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead
MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation
ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.
Science City Road, Ahmedabad 380060
Mon–Sat 11:00–20:00 · +91 97234 31544
Naranpura, Ahmedabad
Mon–Sat 08:30–10:30 · +91 70460 02566